John A Martignetti MD PhD
Women's Health
Professor, Genetics & Genomic Sciences, Pediatrics, Oncology and Obstetrics and Gynecology, Gynecologic Oncology, Icahn School of Medicine
Join to View Full Profile
Mt Sinai School of Medicine1425 Madison Avenue Box 1498New York, NY 10029
Phone+1 212-659-6744
Fax+1 212-849-2638
Dr. Martignetti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Martignetti, based in New York, NY, specializes in Medicine/Pediatrics with a subspecialty in Women's Health. He graduated from the Icahn School of Medicine at Mount Sinai in the class of 1993. His publication record includes research on cancer genetics and therapeutics, with notable works in journals such as Nature Genetics, Gynecologic Oncology and Cancer Cell. Some of his work has been significantly cited, reflecting contributions to the field of endometrial and ovarian cancer research. In 2008, he was elected as a member of The American Society for Clinical Investigation. He is currently CEO and CoFounder of MDDx, Inc. a diagnostic company focusing on women's health.
Education & Training
Icahn School of Medicine at Mount SinaiClass of 1993
Certifications & Licensure
NY State Medical License 1995 - 2026
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2008
Publications & Presentations
PubMed
- 4 citationsMutations in cancer-relevant genes are ubiquitous in histologically normal endometrial tissue.Deep Pandya, Shannon Tomita, Maria Padron Rhenals, Sabina Swierczek, Katherine Reid
Gynecologic Oncology. 2024-06-01 - Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient.Katherine Reid, Olga Camacho-Vanegas, Deep Pandya, Sandra Catalina Camacho, Rui Fang Qiao
Cold Spring Harbor Molecular Case Studies. 2023-12-01 - 30 citationsProteogenomic insights suggest druggable pathways in endometrial carcinoma.Yongchao Dou, Lizabeth Katsnelson, Marina A Gritsenko, Yingwei Hu, Boris Reva
Cancer Cell. 2023-09-11
Press Mentions
Glycemic Control as an Early Prognostic Marker in Advanced Pancreatic CancerFebruary 25th, 2021- Endometrial Cancer Mutations Are Detectable in Uterine Lavage Fluid Before a Cancer Is DiagnosedOctober 23rd, 2020
Danbury Hospital Researchers on Track Developing Tool for More Precise Diagnosis of Gynecologic CancersNovember 14th, 2019
Grant Support
- Role Of The Tumor Suppressor KLF6 In Prostate CancerNational Cancer Institute2010–2011
- Role Of The Tumor Suppressor KLF6 In Prostate CancerNational Cancer Institute2007–2009
- Association Of 7q22..1 Gene VGF With Obesity &LeannessNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2008
- Genetic Dissection Of A Bone Dysplasia/Cancer SyndromeEunice Kennedy Shriver National Institute Of Child Health &Human Development1998–2002
- Positional Cloning Of The Gene For Hereditary Bone DysplasiaNational Center For Research Resources1998–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
